Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence.

[1]  R. Guyton,et al.  Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. , 2003, Cardiovascular research.

[2]  T. Scholz,et al.  Myocardial apoptosis after cardioplegic arrest in the neonatal lamb. , 2003, The Journal of thoracic and cardiovascular surgery.

[3]  W. Weimar,et al.  Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation1 , 2003, Transplantation.

[4]  C. Yeh,et al.  Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis. , 2003, Chest.

[5]  J. Briegel,et al.  Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery , 2003, Critical care medicine.

[6]  D. Sawyer,et al.  &bgr;-Adrenergic Receptor–Stimulated Apoptosis in Cardiac Myocytes Is Mediated by Reactive Oxygen Species/c-Jun NH2-Terminal Kinase–Dependent Activation of the Mitochondrial Pathway , 2003, Circulation research.

[7]  G. Breithardt,et al.  Biochemical mechanisms of hibernation and stunning in the human heart. , 2002, Cardiovascular research.

[8]  M. Waye,et al.  Expression of FHL2 and cytokine messenger RNAs in human myocardium after cardiopulmonary bypass. , 2002, International journal of cardiology.

[9]  G. Biondi-Zoccai,et al.  Clinical relevance of apoptosis in early and late post-infarction left ventricular remodeling. , 2002, Italian heart journal : official journal of the Italian Federation of Cardiology.

[10]  R. Parker,et al.  Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery. , 2002, The Annals of thoracic surgery.

[11]  S. Scolletta,et al.  Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia-reperfusion. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  H. Darius,et al.  Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart. , 2002, The Journal of thoracic and cardiovascular surgery.

[13]  G. Biondi-Zoccai,et al.  Pathophysiologic role of myocardial apoptosis in post‐infarction left ventricular remodeling , 2002, Journal of cellular physiology.

[14]  K. G. Rajesh,et al.  Potential role of mitochondrial permeability transition pore following long-time hypothermic heart preservation. , 2002, Transplantation proceedings.

[15]  G. von Bernuth,et al.  Moderate hypothermia during cardiopulmonary bypass increases intramyocardial synthesis of heat shock protein 72. , 2002, The Journal of thoracic and cardiovascular surgery.

[16]  L. Rochette,et al.  Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model. , 2002, Pathophysiology : the official journal of the International Society for Pathophysiology.

[17]  J. Schmitt,et al.  Kinetics of heat shock protein 70 synthesis in the human heart after cold cardioplegic arrest. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  H. Schultheiss,et al.  Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsies. , 2002, Journal of the American College of Cardiology.

[19]  F. Burzotta,et al.  [Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation]. , 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[20]  J. Schmitt,et al.  Role of apoptosis in myocardial stunning after open heart surgery. , 2002, The Annals of thoracic surgery.

[21]  Douglas B. Cowan,et al.  Selective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosis. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  A. Bryan,et al.  Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[23]  J. Holtz,et al.  Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival? , 2002, Journal of the American College of Cardiology.

[24]  T. Yau,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  A. Zeiher,et al.  Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. , 2001, Journal of the American College of Cardiology.

[26]  G. von Bernuth,et al.  Moderate hypothermia during cardiopulmonary bypass reduces myocardial cell damage and myocardial cell death related to cardiac surgery. , 2001, Journal of the American College of Cardiology.

[27]  S. Hoerstrup,et al.  Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  Y. Toyoda,et al.  Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion. , 2001, The Annals of thoracic surgery.

[29]  Y. Toyoda,et al.  Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection. , 2001, The Annals of thoracic surgery.

[30]  S. Kirchner,et al.  Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[31]  S. Dhein,et al.  Structural myocardial changes after coronary artery surgery , 2000, European journal of clinical investigation.

[32]  N. Maulik,et al.  Oxidative stress developed during open heart surgery induces apoptosis: reduction of apoptotic cell death by ebselen, a glutathione peroxidase mimic. , 2000, Journal of cardiovascular pharmacology.

[33]  B. Schäfer,et al.  Dral Is a P53-Responsive Gene Whose Four and a Half Lim Domain Protein Product Induces Apoptosis , 2000, The Journal of cell biology.

[34]  U. Stammberger,et al.  Apoptosis induced by ischemia and reperfusion in experimental lung transplantation. , 2000, The Annals of thoracic surgery.

[35]  S. Zahler,et al.  Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances. , 2000, The Journal of thoracic and cardiovascular surgery.

[36]  G. Angelini,et al.  Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. , 2000, Cardiovascular research.

[37]  B. Troost,et al.  A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery. , 1999, Journal of cardiothoracic and vascular anesthesia.

[38]  R. Guyton,et al.  Broad-spectrum cardioprotection with adenosine. , 1999, The Annals of thoracic surgery.

[39]  L. Rochette,et al.  Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. , 1999, Journal of cardiovascular pharmacology.

[40]  I. Birdi,et al.  The effects of cardiopulmonary bypass temperature on inflammatory response following cardiopulmonary bypass. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[41]  A. Yim,et al.  Cytokines in myocardial injury: impact on cardiac surgical approach. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[42]  H. Repo,et al.  Nitecapone reduces cardiac neutrophil accumulation in clinical open heart surgery. , 1999, Anesthesiology.

[43]  J. Salo,et al.  Nitecapone as an additive to crystalloid cardioplegia in patients who had coronary artery bypass grafting. , 1999, The Annals of thoracic surgery.

[44]  M. Portman,et al.  Mitochondrial protein and HSP70 signaling after ischemia in hypothermic-adapted hearts augmented with glucose. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[45]  A. Saraste.  Morphologic criteria and detection of apoptosis , 1999, Herz.

[46]  E. Fosse,et al.  Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo. , 1999, The Journal of thoracic and cardiovascular surgery.

[47]  C. Baufreton,et al.  Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. , 1999, The Annals of thoracic surgery.

[48]  E. Marbán,et al.  Molecular and cellular mechanisms of myocardial stunning. , 1999, Physiological reviews.

[49]  S. Zahler,et al.  Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. , 1999, Cardiovascular research.

[50]  N. Maulik,et al.  Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. , 1998, Free radical biology & medicine.

[51]  D. Meldrum.  Tumor necrosis factor in the heart. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[52]  H. Schunkert,et al.  Induction of early immediate genes and programmed cell death following cardioplegic arrest in human hearts. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[53]  G. Hill,et al.  Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. , 1997, Surgery.

[54]  I. Birdi,et al.  Biochemical markers of myocardial injury during cardiac operations. , 1997, The Annals of thoracic surgery.

[55]  J. Hammon,et al.  Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization. , 1997, The Journal of thoracic and cardiovascular surgery.

[56]  H. O. Oudemans-van Straaten,et al.  Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. , 1995, The Journal of thoracic and cardiovascular surgery.

[57]  R. Weisel,et al.  Vitamin E for coronary bypass operations. A prospective, double-blind, randomized trial. , 1994, The Journal of thoracic and cardiovascular surgery.

[58]  R. Weisel,et al.  Vitamin E for coronary bypass operations , 1994 .

[59]  L. Cohn,et al.  Myocardial Stunning and Reperfusion Injury in Cardiac Surgery , 1993, Journal of cardiac surgery.

[60]  C. Hartley,et al.  Clinical relevance of myocardial “stunning” , 1991, Cardiovascular Drugs and Therapy.

[61]  R. Zorc-Pleskovič,et al.  Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[62]  A. Durward,et al.  Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children. , 2002, The Journal of thoracic and cardiovascular surgery.

[63]  A. Halestrap,et al.  Mitochondria: a target for myocardial protection. , 2001, Pharmacology & therapeutics.